Superoxide Dismutase-Overexpressing Mice Are Resistant to Ozone-Induced Tissue Injury and Increases in Nitric Oxide and Tumor Necrosis Factor-α

American Journal of Respiratory Cell and Molecular Biology

Volumn 30, Issue 3, 2004, Pages 280-287

  Fakhrzadeh, Ladan ^b   Laskin, Jeffrey D ^b   Gardner, Carol R ^b   Laskin, Debra L ^a  

^a RUTGERS UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OZONE; PEROXYNITRITE; PHOSPHOLIPASE A2; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; LUNG ALVEOLUS MACROPHAGE; LUNG INJURY; LUNG LAVAGE; LUNG RESISTANCE; MOUSE; NONHUMAN; PNEUMONIA; PROTEIN EXPRESSION; WILD TYPE;

ADMINISTRATION, INHALATION; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CELL SURVIVAL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DRUG RESISTANCE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GLUTATHIONE; INTERLEUKIN-10; ISOENZYMES; LUNG; MACROPHAGES, ALVEOLAR; MALONDIALDEHYDE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; OZONE; PEROXYNITROUS ACID; PHOSPHOLIPASES A; PNEUMONIA; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 1542284719     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2003-0044OC     Document Type: Article

References (35)

1. Grisham, M. B., D. Jourd'heuil, and D. A. Wink. 2000. Chronic inflammation and reactive oxygen and nitrogen metabolism/implications in DNA damage and mutagenesis. Aliment. Pharmacol. Ther. 1:3-9.
2. Muzykantov, V. R. 2001. Delivery of antioxidant enzyme proteins to the lung. Antioxid. Redox Signal. 3:39-62.
3. Davis, J. M. 1998. Superoxide dismutase: a role in the prevention of chronic lung disease. Biol. Neonate 74:29-34.
4. Comhair, S. A., and S. C. Erzurum. 2002. Antioxidant responses to oxidant-mediated lung diseases. Am. J. Physiol. Lung Cell. Mol. Physiol. 283:L246-L255.
5. Noor, R., S. Mittal, and J. Iqbal. 2002. Superoxide dismutase- applications and relevance to human diseases. Med. Sci. Monit. 8:RA210-RA215.
6. Rivas-Arancibia, S., R. Vazquez-Sandoval, D. Gonzalez-Kladiano, S. Schneider-Rivas, and A. Lechuga-Guerrero. 1998. Effects of ozone exposure in rats on memory and levels of brain and pulmonary superoxide dismutase. Environ. Res. 76:33-39.
7. Plopper, C. G., X. Duan, A. R. Buckpitt, and K. E. Pinkerton. 1994. Dose-dependent tolerance to ozone: IV. Site-specific elevation in antioxidant enzymes in the lungs of rats exposed for 90 days or 20 months. Toxicol. Appl. Pharmacol. 127:124-131.
8. Hussain, M. Z., M. G. Mustafa, Q. P. Ghani, and R. S. Bhatnagar. 1985. Stimulation of poly(ADP-ribose) synthetase activity in the lungs of mice exposed to a low level of ozone. Arch. Biochem. Biophys. 24:477-485.
9. Wispe, J. R., B. B. Warner, J. C. Clark, C. R. Dey, J. Neuman, S. W. Glasser, J. D. Crapo, L. Y. Chang, and J. A. Whitsett. 1992. Human Mn-superoxide dismutase in pulmonary epithelial cells of transgenic mice confers protection from oxygen injury. J. Biol. Chem. 267:23937-23941.
10. White, C. W., K. B. Avraham, P. F. Shanley, and Y. Groner. 1991. Transgenic mice with expression of elevated levels of copper-zinc superoxide dismutase in the lungs are resistant to pulmonary oxygen toxicity. J. Clin. Invest. 87:2162-2168.
11. Tsan, M. F. 2001. Superoxide dismutase and pulmonary oxygen toxicity: lessons from transgenic and knockout mice. Int. J. Mol. Med. 7:13-19.
12. Mirochnitchenko, O., and M. Inouye. 1996. Effect of overexpression of human Cu,Zn superoxide dismutase in transgenic mice on macrophage functions. J. Immunol. 156:1578-1586.
13. Lavnikova, N., S. Prokhorova, L. Helyar, and D. L. Laskin. 1993. Isolation and partial characterization of subpopulations of alveolar macrophages, granulocytes, and highly enriched interstitial macrophages from rat lung. Am. J. Respir. Cell Mol. Biol. 8:384-392.
14. Wizemann, T. M., C. R. Gardner, J. D. Laskin, S. Quinones, S. K. Durham, N. L. Goller, S. T. Ohnishi, and D. L. Laskin. 1994. Production of nitric oxide and peroxynitrite in the lung during acute endotoxemia. J. Leukoc. Biol. 56:759-768.
15. Wizemann, T. M., and D. L. Laskin. 1994. Enhanced phagocytosis, chemotaxis, and production of reactive oxygen intermediates by interstitial lung macrophages following acute endotoxemia. Am. J. Respir. Cell Mol. Biol. 11:358-365.
16. Ischiropoulos, H., A. Gow, S. R. Thom, N. W. Kooy, J. A. Royall, and J. P. Crow. 1999. Detection of reactive nitrogen species using 2,7- dichlorodihydrofluorescein and dihydrorhodamine 123. Methods Enzymol. 301:367-373.
17. Rice, G. C., E. A. Bump, D. C. Shrieve, W. Lee, and M. Kovacs. 1986. Quantitative analysis of cellular glutathione by flow cytometry utilizing monochlorobimane: some applications to radiation and drug resistance in vitro and in vivo. Cancer Res. 46:6105-6110.
18. Pendino, K. J., C. R. Gardner, R. L. Shuler, J. D. Laskin, S. K. Durham, D. S. Barton, S. Tsuyoshi, T. Ohnishi, and D. L. Laskin. 1996. Inhibition of ozone-induced nitric oxide synthase expression in the lung by endotoxin. Am. J. Respir. Cell Mol. Biol. 14:516-525.
19. Fakhrzadeh, L., J. D. Laskin, and D. L. Laskin. 2002. Deficiency in inducible nitric oxide synthase protects mice from ozone-induced lung inflammation and tissue injury. Am. J. Respir. Cell Mol. Biol. 26:413-419.
20. Pendino, K. J., R. L. Shuler, J. D. Laskin, and D. L. Laskin. 1994. Enhanced production of interleukin-1, tumor necrosis factor-alpha, and fibronectin by rat lung phagocytes following inhalation of a pulmonary irritant. Am. J. Respir. Cell Mol. Biol. 11:279-286.
21. Hibbs, J. B., Jr. 1991. Synthesis of nitric oxide from L-arginine: a recently discovered pathway induced by cytokines with antitumour and antimicrobial activity. Res. Immunol. 142:565-569.
22. Ischiropoulos, H. 1998. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch. Biochem. Biophys. 356:1-11.
23. Rocca, B., and G. A. FitzGerald. 2002. Cyclooxygenases and prostaglandins: shaping up the immune response. Int. Immunopharmacol. 2:603-630.
24. Hanada, T., and A. Yoshimura. 2002. Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev. 2013:413-421.
25. Li, Q., and I. M. Verma. 2002. NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2:725-734.
26. Laskin, D. L., and K. J. Pendino. 1995. Macrophages and inflammatory mediators in tissue injury. Annu. Rev. Pharmacol. Toxicol. 35:655-677.
27. Lu, Y. C. 1989. Biological effect of qigong waiqi: a preliminary report of the anti-injurious effect of waiqi on ozone toxicity. Zhong Xi Yi Jie He Za Zhi. 710:734-736.
28. Winterbourn, C. C., A. V. Peskin, and H. N. Parsons-Mair. 2002. Thiol oxidase activity of copper, zinc superoxide dismutase. J. Biol. Chem. 277:1906-1911.
29. Forman, H. J., and M. Torres. 2001. Redox signaling in macrophages. Mol. Aspects Med. 22:189-216.
30. Muller, T., H. J. Haussmann, and G. Schepers. 1997. Evidence for peroxynitrite as an oxidative stress-inducing compound of aqueous cigarette smoke fractions. Carcinogenesis 18:295-301.
31. Salvemini, D., E. Mazzon, L. Dugo, D. P. Riley, I. Serraino, A. P. Caputi, and S. Cuzzocrea. 2001. Pharmacological manipulation of the inflammatory cascade by the superoxide dismutase mimetic, M40403. Br. J. Pharmacol. 132:815-827.
32. Kafoury, R. M., W. A. Pryor, G. L. Squadrito, M. G. Salgo, X. Zou, and M. Friedman. 1998. Lipid ozonation products activate phospholipases A2, C, and D. Toxicol. Appl. Pharmacol. 150:338-349.
33. Lu, X. R., W. Y. Ong, and B. Halliwell. 2001. The phospholipase A2 inhibitor quinacrine prevents increased immunoreactivity to cytoplasmic phospholipase A2 (cPLA2) and hydroxynonenal (HNE) in neurons of the lateral septum following fimbria-fomix transection. Exp. Brain Res. 138:500-508.
34. Reinhart, P. G., S. K. Gupta, and D. K. Bhalla. 1999. Attenuation of ozone-induced lung injury by interleukin-10. Toxicol. Lett. 110:35-42.
35. Schottelius, A. J., M. W. Mayo, R. B. Sartor, and A. S. Baldwin. 1999. Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. J. Biol. Chem. 274:31868-31874.